Aptevo Therapeutics Inc. Line of Credit Facility, Maximum Borrowing Capacity
Aptevo Therapeutics Inc. (APVO) had Line of Credit Facility, Maximum Borrowing Capacity of $25.00 million as of 2020-08-05, per its 10-K filed 2024-03-05.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2024-03-05
- 2020-08-05: Line of Credit Facility, Maximum Borrowing Capacity $25.00M.
- 2020-05-08: Line of Credit Facility, Maximum Borrowing Capacity $25.00K.
- 2016-08-04: Line of Credit Facility, Maximum Borrowing Capacity $35.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2020-08-05 | $25.00M 10-K · filed 2024-03-05 |
| 2020-05-08 | $25.00K 10-K · filed 2022-03-24 |
| 2016-08-04 | $35.00M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |